342 related articles for article (PubMed ID: 17374922)
21. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
22. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
Booth J; Zavgorodni S
Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric consequences of intrafraction prostate motion.
Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
[TBL] [Abstract][Full Text] [Related]
24. Margins for treatment planning of proton therapy.
Thomas SJ
Phys Med Biol; 2006 Mar; 51(6):1491-501. PubMed ID: 16510958
[TBL] [Abstract][Full Text] [Related]
25. Collapsed cone convolution and analytical anisotropic algorithm dose calculations compared to VMC++ Monte Carlo simulations in clinical cases.
Hasenbalg F; Neuenschwander H; Mini R; Born EJ
Phys Med Biol; 2007 Jul; 52(13):3679-91. PubMed ID: 17664570
[TBL] [Abstract][Full Text] [Related]
26. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.
Stroom JC; de Boer HC; Huizenga H; Visser AG
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):905-19. PubMed ID: 10098447
[TBL] [Abstract][Full Text] [Related]
27. A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization.
Yang J; Mageras GS; Spirou SV; Jackson A; Yorke E; Ling CC; Chui CS
Med Phys; 2005 Aug; 32(8):2567-79. PubMed ID: 16193787
[TBL] [Abstract][Full Text] [Related]
28. An assessment of action levels in imaging strategies in head and neck cancer using TomoTherapy. Are our margins adequate in the absence of image guidance?
Houghton F; Benson RJ; Tudor GS; Fairfoul J; Gemmill J; Dean JC; Routsis DS; Jefferies SJ; Burnet NG
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):720-7. PubMed ID: 19740637
[TBL] [Abstract][Full Text] [Related]
29. Combined recipe for clinical target volume and planning target volume margins.
Stroom J; Gilhuijs K; Vieira S; Chen W; Salguero J; Moser E; Sonke JJ
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):708-14. PubMed ID: 24113058
[TBL] [Abstract][Full Text] [Related]
30. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.
Haedinger U; Krieger T; Flentje M; Wulf J
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):239-49. PubMed ID: 15629617
[TBL] [Abstract][Full Text] [Related]
31. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
32. PTV margin determination in conformal SRT of intracranial lesions.
Parker BC; Shiu AS; Maor MH; Lang FF; Liu HH; White RA; Antolak JA
J Appl Clin Med Phys; 2002; 3(3):176-89. PubMed ID: 12132939
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
Balter JM; Brock KK; Lam KL; Tatro D; Dawson LA; McShan DL; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):610-4. PubMed ID: 16095848
[TBL] [Abstract][Full Text] [Related]
34. Poster - Thur Eve - 62: Assessing the clinical application of the van Herk margin formula for lung radiotherapy.
Ecclestone G; Heath E; Bissonnette JP
Med Phys; 2012 Jul; 39(7Part3):4636. PubMed ID: 28516702
[TBL] [Abstract][Full Text] [Related]
35. Variable planning margin approach to account for locoregional variations in setup uncertainties.
Yang J; Garden AS; Zhang Y; Zhang L; Dong L
Med Phys; 2012 Aug; 39(8):5136-44. PubMed ID: 22894439
[TBL] [Abstract][Full Text] [Related]
36. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
37. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
[TBL] [Abstract][Full Text] [Related]
38. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
[TBL] [Abstract][Full Text] [Related]
39. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Hsu A; Pawlicki T; Luxton G; Hara W; King CR
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
[TBL] [Abstract][Full Text] [Related]
40. Coping with interfraction time trends in tumor setup.
Giżyńska MK; Kukołowicz PF; Heijmen BJM
Med Phys; 2020 Feb; 47(2):331-341. PubMed ID: 31721232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
